Login
← Go Back
Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022
Stock Price vs Company Growth
1d
0.4%
1w
6.4%
1m
7.7%
3m
5.4%
6m
4.7%
1y
56.9%
all
7.0%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec21Jun22Dec22Jun23Dec23Jun24Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 222 0.4%
180
252
Company Overview
Sales
8,949 Cr
Growth: 13.5%
Profit after Tax
38.9 Cr
Growth: -14.2%
Mid Cap
29,379 Cr
P/E: 740.3x
Industry P/E: 30.6x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 8,949
Growth 13.5%
EBITDA 15.8%
P/S 3.3x
Dividend 0.1%
P/E 740.3x
Book Value ₹ 59.2
PEG Ratio 54.9x
ROE 0.5%
P/B 3.8x
Shareholding Pattern
Institutions
Created with Highcharts 8.2.2Sep22Sep23Dec23Jun24Sep24
Promoters
Created with Highcharts 8.2.2Sep22Sep23Dec23Jun24Sep24
Others
Created with Highcharts 8.2.2Sep22Sep23Dec23Jun24Sep24
Increase    Decrease    No change
Company Profile Detailed
The company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across many global facilities and a global distribution network in hundreds of countries. It includes PPS, PCC and the India Consumer Healthcare business, selling over-the-counter products.
Belongs to (25 Indices) view more
Investors (5)
an.sujay
vskr63
chethan3
Followers (2)
saurabh8...
varsha96